ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000739.1|Capsular_2 # 699 # 2567 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=4bp;gc_cont=0.324	BGC0000739.1|Capsular_2 	699	2567	+	Loose	1200	27.7202	tet(T)	29.85	3000193	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAAAAGGTTATTATCATTGGACATAAACAGTCTAACTATCAAGATGTTGAAAAGGTTTTTCAATGTTATGGGATGAATCCCCCGCTTCCATCAAAACGTGAAAAAATGTCCCCCATCGAAATTGGCCATGTACTTAATAAAGTATTACCAAGTCTTGAGCACACACCTAAAAATGTATCTTTACTTTCTAATAAGAAAAGCAAAATAAAAAAAGGGAATTCAGCCAAAAATAAATCTCATAAGCACGCTAAAACGAACACAATACAAACGACTTCGAGCATCTGGGATAACTTATCTCTCGATTTGATGCTCGCGAATATCGAGCAAAATTTTTGGGGATGGTCTGATCCTAATGCAATTCAAATATTAGATTATTGGGCTAACCTTGACCCAAACATTCATTTCGTCTTTGTTTATGATAAGCCAGAAAATTTATTCCAATATCATAGCTTAGAAGAGGCTCTCAAATTAGATAAACACACCGTACAAGAAAAATTTGAAGAGTGGCAAACCTACAATGAAAAAATCCTAACTTACTTTAATAAATATAAAGATCGTAGTGTATTACTGAATACACAACAACTCCAAAATACGAAAAAAACATCACTGTCTGAAATTTATAAACATATTTCTGCACCTGATGCATTAGTCAAAAAACTGAATGAACCTTCTCTAAATAAAGAGATGGAAATTATTGAAGTAAACCAAGATTTATCTCACCAAGAAGAATGTCCACTGTCTAACTTTATTGTTAGCCAAATTATAAAAAATTCTCCTACTGTTACGCAGGTATATGAAGAATTACAGTCGCATGCTGATCTGCCTTATATTTCAGAACAAAAATTAGTAAATGATGCCGATTTTGCTCTCCTTGCATGGAAAGATATGATTCAAAAAAAAGTCGATGTAAATCAATATCAACATGAAAAAGAATTAGAACTTAGCACAATAAAAGAACGTCAATTAGAGGTCACAGAGAGATATCAATTGACGGAACAAAAACTGTCAGAAACACAAAAAGAAATCGAACAAATTAAAGATGAAAATAGAAAAGTAAAATCTGAAAAAGCAAAACTCACTGCATCTGTTCAATCAACGAGCAAAATACTTTCTGAGAAAGAAAAAGAGATTTCTTGCATAAAAAGTGAAAATACAAAGATTAAAGAAGAAAAAATTAAAATTGATGAAGCATACCACTTAACCAAGAAAACCTTGTCGGATAAAGAAAAAGCCCTCAAAACGCATCAAGATGAAATTGAAGCGCTCAAGATAATTTTTAATGAAAATATTTCCGTACAAGAAGATATGCAAGAAAAATTTCAGGAAGCCAATAAAAGAAAACAAGAACTTGAACAAGAGCTAAAAGCCATATCGGATAAGAAAGCATTATTAGAAACAGAAAACAGCCAAAAAACCCAAGTATCTGAGTCTTTAGAAAATGAAAATAAAGTGTTATTAGCTCAACTCCAACTCATTCAAGAAGAATTAGAAAAACTTTATATTGACAATCAAGTATTAAAAGCTAAACCACGCCTTTACGGTGCAGCTGATCGCATAAAAAACCAATTAACTTATCGACTAGGTTACAAAATACAAAGACATGGAAGAAGTCTATTTGGTCTCATTTTTCTTCCTTTCATCTTATTTTTCACCTATCTGGGCTTTAAAAGAGAGATGAAAAAGTACGAGTGGAATACGCTCCCACCAATTCATGAATATGAAGATGCGCATGAAGCCAATCGCATTAAAAGCCATTTATCTTATAAATTGGGCGTCCTCTTTTTGCAAGAAATCAACAATCCGTTTAAGTGGCTTACTCTCCCTTATAAACTGATTAAAGAAGGTAAACGATTCAAGCAAGGTTAA	MKKVIIIGHKQSNYQDVEKVFQCYGMNPPLPSKREKMSPIEIGHVLNKVLPSLEHTPKNVSLLSNKKSKIKKGNSAKNKSHKHAKTNTIQTTSSIWDNLSLDLMLANIEQNFWGWSDPNAIQILDYWANLDPNIHFVFVYDKPENLFQYHSLEEALKLDKHTVQEKFEEWQTYNEKILTYFNKYKDRSVLLNTQQLQNTKKTSLSEIYKHISAPDALVKKLNEPSLNKEMEIIEVNQDLSHQEECPLSNFIVSQIIKNSPTVTQVYEELQSHADLPYISEQKLVNDADFALLAWKDMIQKKVDVNQYQHEKELELSTIKERQLEVTERYQLTEQKLSETQKEIEQIKDENRKVKSEKAKLTASVQSTSKILSEKEKEISCIKSENTKIKEEKIKIDEAYHLTKKTLSDKEKALKTHQDEIEALKIIFNENISVQEDMQEKFQEANKRKQELEQELKAISDKKALLETENSQKTQVSESLENENKVLLAQLQLIQEELEKLYIDNQVLKAKPRLYGAADRIKNQLTYRLGYKIQRHGRSLFGLIFLPFILFFTYLGFKREMKKYEWNTLPPIHEYEDAHEANRIKSHLSYKLGVLFLQEINNPFKWLTLPYKLIKEGKRFKQG	MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRASTVSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLNIPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQIIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFAITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIKSLESIMNGEIVKVGQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPCDLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILRLFGNIQMEVIESLLKSRYKIDARFGELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSFQNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGTEILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSELLSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN	95.55	gnl|BL_ORD_ID|1954|hsp_num:0	2037			423	618	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000739.1|Capsular_3 # 2584 # 5481 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=9bp;gc_cont=0.313	BGC0000739.1|Capsular_3 	2584	5481	+	Loose	550	33.8834	PmrF	28.97	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAATACATTATCACAAGCAATAAAAGCATATAACAGCAATGACTATGAATTAGCACTCAAATTATTTGAGAAGTCTGCTGAAACCTACGGGCGAAAAATCGTTGAATTCCAAATTATCAAATGTAAAGAAAAACTCTCGACCAATTCTTATGTAAGTGAAGATAAAAAAAACAGTGTTTGCGATAGCTCATTAGATATCGCAACACAGCTCTTACTTTCCAACGTAAAAAAATTAACTCTATCCGAATCAGAAAAAAACAGTTTAAAAAATAAATGGAAATCTATCACTGGGAAAAAATCGGAGAACGCAGAAATCAGAAAGGTGGAACTAGTACCCAAAGATTTTCCTAAAGATCTTGTTCTTGCTCCATTGCCAGATCATGTTAATGATTTTACATGGTACAAAAATCGAAAAAAAAGCTTAGGTATAAAGCCTGTAAATAAGAATATCGGTCTTTCTATTATTACTCCTACATTTAATCGTAGCCGTATTTTAGATATAACGTCAGCCTGTTTGGTCAATCAGAAAACAAACTACCCATTTGAAGTCGTTGTTGCAGATGATGGTAGTAAGGAAAACTTACTTACCATTGTGCAAAAATACGAACAAAAACTTGACATAAAGTATGTAAGACAAAAAGATTATGGATATCAATTGTGTGCAGTCAGAAACTTAGGTTTACGTACAGCAAAGTATGATTTTGTCTCGATTCTAGACTGCGATATGGCACCACAACAATTATGGGTTCATTCTTATCTTACAGAACTATTAGAAGACAATGATATTGTTTTAATTGGACCTAGAAAATATGTGGATACTCATAATATTACCGCAGAACAATTCCTTAACGATCCATATTTAATAGAATCACTACCTGAAACCGCTACAAATAACAATCCTTCGATTACATCAAAAGGAAATATATCGTTGGATTGGAGATTAGAACATTTCAAAAAAACCGATAATCTACGTCTATGTGATTCACCGTTTCGTTATTTTAGTTGCGGTAATGTTGCATTTTCTAAAGAATGGCTAAATAAAGTAGGTTGGTTCGATGAAGAATTTAATCATTGGGGGGGCGAAGATGTAGAATTTGGTTACAGATTATTTGCCAAAGGCTGTTTTTTCAGAGTAATTGACGGCGGAATGGCATACCATCAAGAACCACCTGGTAAAGAAAATGAAACAGACCGCGAAGCTGGTAAAAGTATTACGCTTAAAATTGTGAAAGAAAAGGTACCTTACATCTATAGAAAGCTTTTACCAATAGAAGATTCACATATTCATAGAATACCTTTAGTTTCTATTTATATCCCCGCTTATAACTGTGCAAATTATATTCAAAGATGTGTAGATAGTGCTCTTAATCAAACTGTTGTCGATCTCGAGGTTTGTATTTGTAACGATGGTTCAACAGATAATACCTTAGAAGTGATCAATAAGCTTTATGGTAATAATCCTAGGGTACGCATCATGTCTAAACCAAATGGCGGAATAGCCTCAGCATCAAATGCAGCCGTTTCTTTTGCTAAAGGTTATTACATTGGGCAGTTAGATTCAGATGATTATCTTGAGCCTGATGCAGTTGAACTGTGTTTAAAAGAATTTTTAAAAGATAAAACGCTAGCTTGTGTTTATACCACTAATAGAAACGTCAATCCGGATGGTAGCTTAATCGCTAATGGTTACAATTGGCCAGAATTTTCACGAGAAAAACTCACAACGGCTATGATTGCTCACCACTTTAGAATGTTCACGATTAGAGCTTGGCATTTAACTGATGGATTCAATGAAAAAATTGAAAATGCCGTAGACTATGACATGTTCCTAAAACTCAGTGAGGTTGGAAAATTTAAGCATCTTAATAAAATTTGTTATAACCGCGTATTACATGGTGATAATACATCAATTAAAAATCTAGACACTCAAAAGAAAAATCATTTCGTTGTCGTTAATCAATCATTAAATAGGCAGAGAGTAAGTAATTATAACTATGATGAATTCGATAACTTAGATGAAAGTAGAAAATACATTTTCAATAAAACAGCAGATTATCAAGAAGAAATTGATATTCTAAAAGATATCAAAATAGTACAGCGTAAAGATGCAAAAGTTGCAATAAGTATATTTTATCCAAATAGATTAGATGGGTTAGTTAAAAAATTAAACAATATTATCGAATATAACAAAAATGTACTCATTATTGTTTTACACATTGACAAAAATCATCTCACTTCAGACATCAAAAAGGAAATACTAGAATTTCATAACAAGAATCAAATCAATATCTTGTTAAATAATGATGTTTCTTATTATACAAACAACAGGCTCATAAAAACTAAAGCTCATTTAAGCAATATGAACAAGTTAAGACAACTAAATCTTAATTTAGAATATATTATTTTTGACAACCATGACAGCCTATTTATTAAAAATGATAGTTATAACCATATAAAAAAATATGATATCGGCATGAACTTCTCCTCATTAACAAATGATTGGATAAATAAAATTAATGCACACTCACCATTTAAAAATCTGATAAAAAAATATTTTAATGATAATGATTTAAAAACAATAAATATGAAAGGCGCGTCACAAGGAATGTTCATAAAATACACTTTAGCACATGATATTGCTACGATTATGAAAGAAGTCATTACATTATGCCAATCTACAGATAGTGTTCCTGAATATAATACTGAAGATATTTGGTTCCAATTTGCACTTTTAATCTTAGAAAAGAAAACCGGCCATGTATTTAATAAAACATCGACCCTGACTTATATGCCTTGGGAACGAAAATTACAATGGACAAATGAACAAATTGAAAGTGCAAAAAGAGGAGAAAATATACCTGTTAACAAGTTCATTATTAATAGTATAACTCTATAA	MNTLSQAIKAYNSNDYELALKLFEKSAETYGRKIVEFQIIKCKEKLSTNSYVSEDKKNSVCDSSLDIATQLLLSNVKKLTLSESEKNSLKNKWKSITGKKSENAEIRKVELVPKDFPKDLVLAPLPDHVNDFTWYKNRKKSLGIKPVNKNIGLSIITPTFNRSRILDITSACLVNQKTNYPFEVVVADDGSKENLLTIVQKYEQKLDIKYVRQKDYGYQLCAVRNLGLRTAKYDFVSILDCDMAPQQLWVHSYLTELLEDNDIVLIGPRKYVDTHNITAEQFLNDPYLIESLPETATNNNPSITSKGNISLDWRLEHFKKTDNLRLCDSPFRYFSCGNVAFSKEWLNKVGWFDEEFNHWGGEDVEFGYRLFAKGCFFRVIDGGMAYHQEPPGKENETDREAGKSITLKIVKEKVPYIYRKLLPIEDSHIHRIPLVSIYIPAYNCANYIQRCVDSALNQTVVDLEVCICNDGSTDNTLEVINKLYGNNPRVRIMSKPNGGIASASNAAVSFAKGYYIGQLDSDDYLEPDAVELCLKEFLKDKTLACVYTTNRNVNPDGSLIANGYNWPEFSREKLTTAMIAHHFRMFTIRAWHLTDGFNEKIENAVDYDMFLKLSEVGKFKHLNKICYNRVLHGDNTSIKNLDTQKKNHFVVVNQSLNRQRVSNYNYDEFDNLDESRKYIFNKTADYQEEIDILKDIKIVQRKDAKVAISIFYPNRLDGLVKKLNNIIEYNKNVLIIVLHIDKNHLTSDIKKEILEFHNKNQINILLNNDVSYYTNNRLIKTKAHLSNMNKLRQLNLNLEYIIFDNHDSLFIKNDSYNHIKKYDIGMNFSSLTNDWINKINAHSPFKNLIKKYFNDNDLKTINMKGASQGMFIKYTLAHDIATIMKEVITLCQSTDSVPEYNTEDIWFQFALLILEKKTGHVFNKTSTLTYMPWERKLQWTNEQIESAKRGENIPVNKFIINSITL	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	299.69	gnl|BL_ORD_ID|1937|hsp_num:0	2014			9	330	polymyxin B
BGC0000739.1|Capsular_4 # 5545 # 6717 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AATAA;rbs_spacer=10bp;gc_cont=0.350	BGC0000739.1|Capsular_4 	5545	6717	+	Loose	700	479.945	ugd	58.66	3003577	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAAGAAAATTACAATTGCTGGGGCTGGCTATGTTGGTTTATCCAATGCAGTATTATTAGCTCAACACCACAATGTGATCTTATTAGATATTGATCAAAATAAAGTTGATTTAATTAATAATAAAAAATCGCCCATCACAGATAAAGAAATGGAAGATTTCTTACAAAATAAATCACTGACAATGATGGCAACACCAGATAAAGAAGTGGCATTAAAAAACGCAGACTTTGTCATCAACGCAACGCCACCAGACTATAATACCGAAACAGGTTATTTTAATACATCCACTGTTGAAGCTGTCATTGAACAAACCCTTTCAATCAATCCACAAGCAGCGATTATTATAAAATCAACAATTCCCGTTGGTTTTACCGAAAACATGCGTGAAAAATTTAATACCCCAAATCTTATCTTTTCACCTGAATTTCTAAGAGAGGGAAAAGCCCTTTACGATAATTTGTATCCAAGCAGAATTATTGTTGGCAGTACTTCTTATCAAGCAAAAGTATTTGCCGATATGTTGACACAGTGTGCCAGAAAAAAAGATGTAACTGTTTTATTTACACACAATACTGAGGCCGAAGCTGTTAAATTATTTGCAAATACGTATCTCGCAATGCGAGTTGCCTTTTTTAATGAATTAGATACTTATGCGAGTCTTCACCATTTAAATACAAAAGACATTATCAATGGTATTTCTACTGATCCTCGCATTGGTACACACTACAATAACCCAAGTTTCGGCTATGGCGGTTATTGTTTACCCAAAGACACTAAACAGTTACTGGCTAACTATGCTGACGTGCCTCAAAATCTCATTGAAGCCATTGTCAAATCTAATGAAACCAGAAAACGTTTCATTACTCATGATGTATTAAATAAGAAACCTAAAACTGTTGGTATTTATCGTTTAATCATGAAGTCAGGTTCTGATAACTTCAGAGCTTCTGCTATTCTCGATATTATGCCGCATCTCAAAGAAAACGGTGTTGAGATTGTGATTTATGAGCCAACCTTAAATCAACAGGCATTTGAGGACTACCCCGTTATTAATCAACTCTCTGAATTTATTAATCGCTCTGATGTCATTCTCGCTAATCGTTCTGAGCCAGATTTAAATCAATGTTCCCATAAAATCTATACAAGAGATATTTTTGGCGGTGATGCTTAA	MKKITIAGAGYVGLSNAVLLAQHHNVILLDIDQNKVDLINNKKSPITDKEMEDFLQNKSLTMMATPDKEVALKNADFVINATPPDYNTETGYFNTSTVEAVIEQTLSINPQAAIIIKSTIPVGFTENMREKFNTPNLIFSPEFLREGKALYDNLYPSRIIVGSTSYQAKVFADMLTQCARKKDVTVLFTHNTEAEAVKLFANTYLAMRVAFFNELDTYASLHHLNTKDIINGISTDPRIGTHYNNPSFGYGGYCLPKDTKQLLANYADVPQNLIEAIVKSNETRKRFITHDVLNKKPKTVGIYRLIMKSGSDNFRASAILDIMPHLKENGVEIVIYEPTLNQQAFEDYPVINQLSEFINRSDVILANRSEPDLNQCSHKIYTRDIFGGDA	MKITISGTGYVGLSNGLLIAQNHEVVALDILPSRVAMLNDRISPIVDKEIQQFLQSDKIHFNATLDKNEAYRDADYVIIATPTDYDPKTNYFNTSSVESVIKDVVEINPYAVMVIKSTVPVGFTAAMHKKYRTENIIFSPEFLREGKALYDNLHPSRIVIGERSERAERFAALLQEGAIKQNIPMLFTDSTEAEAIKLFANTYLAMRVAYFNELDSYAESLGLNSRQIIEGVCLDPRIGNHYNNPSFGYGGYCLPKDTKQLLANYQSVPNNLISAIVDANRTRKDFIADAILSRKPQVVGIYRLIMKSGSDNFRASSIQGIMKRIKAKGVEVIIYEPVMKEDSFFNSRLERDLATFKQQADVIISNRMAEELKDVADKVYTRDLFGSD	100.52	gnl|BL_ORD_ID|894|hsp_num:0	842			3	1164	polymyxin B
BGC0000739.1|Capsular_5 # 6710 # 8143 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.342	BGC0000739.1|Capsular_5 	6710	8143	+	Loose	550	41.2022	PmrF	27.52	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCTTAACCTGTTTAAAATCATAAAAAAGTATGTGCATATTCAATCTTTATTACACAAAAAAGAATATGCCTTACTTTATGCTAAATACATAAACCAGCTTTCTATCAACCAGCAGGCTTATGTTATTTGTCAACTCAAACTCTATGATCTCTTTCTGATTGATCCTAAATGGAGCCACTCTGTTTTTTTCCAGTTAGGATTAATTGCTCGTGGACACGATCATGATAGCGATGAAATGGTACGTCGTTTGATCACTTGCACTGATTTTAGCAAAAATAAGCAGTTAATCCTTTCTCAATTACTTGCTTATTCACCTCAAATTGCAACAACATTATGTCCACAGACATATCGTTATCGTGCGCTATATCTCTCATTACTAGCGAATTTAAAAGACTTTGTTCGTTTAAAAGAAGAACTCAATAAGTTGCCGTCATGTGTGTTAAAGAATACACCTCATTACTGTTTGTTACAGAATTTTGTCGAAAAAGAAAACAGCAAGAAATTAGAGAACATTAATCAATTTCTTTACTTTTATAAACTTGGAGAAATAACTACGATAAAGACAGAAGATCCACCTAATACTAATAATATAGTCAGTCATTCGATAGTTAATGACACAAACACCTACTTAAATGCCCCTTTAATTACCATATTAGTGACGACATTTAACAGTCAAAAAAGTATAAAAAACACATTAAATTCATTGTTCAATCAAAGCTATCCAAATATTGAAATTATCGTTATTGATGATCATAGCCAAGATAATACGATGAGTATTCTCCAGGCTTATACTAAGCAATATAAAAATATCAAAATCATTAGCTTAAAAGAAAATGTCGGGACTTATGTCGCAAAAAATATTGGGCTTAAATACGCCTCTGGCGAATTCATCACTTGTCAAGATTCCGATGATTGGGCACACCCACAAAAATTGGCACTTCAGGTGGCTCCTTTATTACAACATAAAGAGTTAATTGTAACTTTTTCTAAGTGGGTAAGGCTCGATCCAATAGGGAATCCTTATGCCCGTACTATTTATCCATTAATGCGTTTAAACCCTTCTTCCGCATTATTCCGTAAAAAAGAAGTGTGTGAAAAAACTGCATTATGGGATTGGGTAAGAATCGGTGCAGATAGCGAATTTAATGCACGCTTAAAATTAATTTTTGGACACAAAGGCTATTACACCGTGAATAAACCTTTGACATTCGGTGCACATCGAGAAAATTCATTAATGACAGCTCAAAGTACTGGCTATGTCAATGGCGTCTCCCTACCTCGTGAAGCATATTGGAAAGCATGGAATATCTGGCATATCTCACAATTACAGCGAGGACACGCCCCTCTTTTATCTTCCTCTCCTAAACGAGAATTTTTTCAATATGACCAACATCCGATCATGGATGTTATTTCTTATGCAATCATTAATTAA	MLNLFKIIKKYVHIQSLLHKKEYALLYAKYINQLSINQQAYVICQLKLYDLFLIDPKWSHSVFFQLGLIARGHDHDSDEMVRRLITCTDFSKNKQLILSQLLAYSPQIATTLCPQTYRYRALYLSLLANLKDFVRLKEELNKLPSCVLKNTPHYCLLQNFVEKENSKKLENINQFLYFYKLGEITTIKTEDPPNTNNIVSHSIVNDTNTYLNAPLITILVTTFNSQKSIKNTLNSLFNQSYPNIEIIVIDDHSQDNTMSILQAYTKQYKNIKIISLKENVGTYVAKNIGLKYASGEFITCQDSDDWAHPQKLALQVAPLLQHKELIVTFSKWVRLDPIGNPYARTIYPLMRLNPSSALFRKKEVCEKTALWDWVRIGADSEFNARLKLIFGHKGYYTVNKPLTFGAHRENSLMTAQSTGYVNGVSLPREAYWKAWNIWHISQLQRGHAPLLSSSPKREFFQYDQHPIMDVISYAIIN	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	148.14	gnl|BL_ORD_ID|1937|hsp_num:0	2014			27	345	polymyxin B
BGC0000739.1|Capsular_6 # 8162 # 8836 # 1 # ID=1_6;partial=01;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.385	BGC0000739.1|Capsular_6 	8162	8836	+	Loose	1000	27.7202	vga(E) Staphylococcus cohnii	30.61	3004715	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	vga-type ABC-F protein	ATGAAACCAATAAAAACATTATCTATTTCTTTTATCACAACGCTCATCCTCGCTGGCTGTCATAGCATGCCAACTTCGGGACCCGGTCAAAATCATATTATTGGGTTAAAAAAACCACAAAATGAGAGCTTGCCAAGTGTTGATGTGATTGAAATGAATGATAAAGTAGCACACACTTTGTTTAAACAAAAGCAATCGCAATCCTTTACTCAATTCAAACAGCAAAATAGCAACTATGCAGATATCATTAATGTTGGCGATACATTAGATGTGTTGATTTGGGAAGCCGCACCCGCTATTTTATTCGGCAGTGTTCTGTCACAAACTGGTAGTGGCGGTGCAAATCTCACGACATTACCCGAACAAATTGTTGCACGCAATGGAAAAATCACAATCCCATTTTTAGGCCCTATCTTAGTAAAAGGCAAAACACCAGAGCAAATTCAAAGAGATATTGCTCATGCTTTATCCTCCTTAGCAAATAAACCTCAGGTGATTGTTCGTTTAAATAAAAATAATTCAAAAAATGTCACCATTCTCCGCCAAGGCAATAGTGTCAGAATGCCATTAACATCACAAGGGGAACGTGTACTTGATGCTATTGCCGCAGTGGGCGGTGCCACAGAAAATCTACAAGATATTTCTGTTCAACTTACACGTGGTAAAGAAGTAAAA	MKPIKTLSISFITTLILAGCHSMPTSGPGQNHIIGLKKPQNESLPSVDVIEMNDKVAHTLFKQKQSQSFTQFKQQNSNYADIINVGDTLDVLIWEAAPAILFGSVLSQTGSGGANLTTLPEQIVARNGKITIPFLGPILVKGKTPEQIQRDIAHALSSLANKPQVIVRLNKNNSKNVTILRQGNSVRMPLTSQGERVLDAIAAVGGATENLQDISVQLTRGKEVK	MLLFEGTSIKKQLHDRVLFDIDLIQVHDNQRIGLVGRNGTGKTSLLKIITGEELPDEGNISPFTSVKLVPQFKESRLEKSGGEITQQYLQNAFNGNPGLLLLDEPTTHLDTERIAWLEKKIRNYQGAAVVVSHDRTFLNNVCTDIWEIEKNTLKIFKGNYDEYAKQKEILKKQKQTEFEKYEREKQKLERAIRQKEERAQRATKKPKNLSSSEARIVGAKTHYANIQKKLRSSAKALETRLEQLDKVDKVKELPEIKMDMLNEENLTNQSVLRAENIKGEIEERKLWEPFSLYLYGGDKVAIIGKNGSGKTTLLKKIVKQDEGVTIPEKVKIGYFSQHLTILNDEKSIIENVQSTSSQNETLIRTVLARMHFWDEDVYKKVGILSGGEKVKLALAKLFLSEVNMLVLDEPTNFLDIAALEALETLMKSYHGTILFVTHDRMLVKNIATKIIDIKDGKITVFDGSYEAYEEWLENKTKSNNDDQLLLIETKISDVLGRLSLEPSQELEDEFQRLLKEKKELTRGE	42.94	gnl|BL_ORD_ID|2247|hsp_num:0	3400			834	981	lincomycin; clindamycin; virginiamycin M1; tiamulin; retapamulin; valnemulin
